Firmenich, the world's first private perfume and flavouring company, has appointed Sarah Reisinger as Chief Research Officer, effective July 1, 2021. Dr. Reisinger will report to the group's CEO, Gilbert Ghostine, as a member of his executive team after most recently serving as Senior Vice President of Research Operations. She succeeds Professor Geneviève Berger, who remains as strategic advisor to the CEO, before retiring on December 31, 2021.
In his new role, Dr. Reisinger will lead Firmenich to the new frontiers of scientific excellence, building on the Group's capital for cutting-edge innovation.
"Sarah brings a unique combination of world-class research and development management experiences, both in start-ups and large groups, with a solid background in biotechnology, augmented discovery and open innovation. I am very proud to welcome him to my management team. "said Gilbert Ghostine. "Firmenich is shaping the future of fragrance and taste, and this next-generation appointment demonstrates our commitment to providing our customers with cutting-edge technology and sustainable solutions that meet evolving consumer needs."
"I am excited to conduct scientific research in changing fields and integrate new technologies, based on our heritage of scientific excellence." said Dr. Reisinger. "Our team's multidisciplinary and comprehensive approach to innovation in fragrances, taste and ingredients is a huge asset in delivering revolutionary solutions to our customers."
"I would like to thank Professor Berger warmly for his success in developing the field of our research and development activity and for defending white biotechnology. Under his leadership, we have expanded research and strengthened our global scientific footprint with new research and development centers, targeted acquisitions, and we have been the first to commercialize AI-generated solutions in the field of fragrances and aromas. "said Gilbert Ghostine. "I will continue to build on his world-class scientific and commercial expertise over the coming months."
Dr. Reisinger has extensive expertise in biotechnology and extensive experience in developing ingredients and technologies for the consumer goods sector. Prior to joining Firmenich in 2018 as VP of Biotechnology and Process Engineering, she held key roles at Ginkgo Bioworks, Intrexon and Amyris. She began her career in the field of cancer biology and treatment. Ms. Reisinger holds a bachelor's degree in biology from Harvey Mudd College in the United States, a master's degree in plant biology and a doctorate in microbiology from the University of California, Berkeley.